NSE BSE
sudarshan pharma industries li stock

SUDARSHAN PHARMA INDUSTRIES LI Share Price

- - (%)
- NSE: SUDARSHAN

SUDARSHAN PHARMA INDUSTRIES LI Share Price Update

As of the latest trading session, SUDARSHAN PHARMA INDUSTRIES LI share price is currently at 100, which is up by 5.15 from its previous closing. Today, the stock has fluctuated between 96.00 and 100.00. Over the past year, SUDARSHAN PHARMA INDUSTRIES LI has achieved a return of 50.55 %. In the last month alone, the return has been 18.77 %. Read More...

SUDARSHAN PHARMA INDUSTRIES LI Performance

Day Range

Low96.00 High100.00
100.00

52 Week Range

Low 58.20 High 100.00
100.00

SUDARSHAN PHARMA INDUSTRIES LI Share Price

543828

SUDARSHAN

img img img img
No Data Available

Open Price

96.00

Prev. Close

94.85

Volume (Shares)

302400.00

Total traded value

302.40

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

SUDARSHAN PHARMA INDUSTRIES LI Fundamentals


(Standalone)

Market Cap (Cr) 240.65
PE Ratio (TTM) 20.10
Book Value / Share 46.37
Beta 0.50
ROE 10.77%
EPS (TTM) 4.72
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.00

SUDARSHAN PHARMA INDUSTRIES LI Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 465.56
Operating Expense 453.21
Net Profit 11.36
Net Profit Margin (%) 2.44
Earnings Per Share (EPS) 4.72
EBITDA 25.36
Effective Tax Rate (%) 24.76
Particulars MAR 2023 (Values in Cr)
Revenue 461.33
Operating Expense 452.95
Net Profit 7.04
Net Profit Margin (%) 1.52
Earnings Per Share (EPS) 5.48
EBITDA 15.81
Effective Tax Rate (%) 25.89
Particulars MAR 2022 (Values in Cr)
Revenue 357.09
Operating Expense 350.42
Net Profit 5.25
Net Profit Margin (%) 1.47
Earnings Per Share (EPS) 5.46
EBITDA 11.38
Effective Tax Rate (%) 26.47
Particulars MAR 2021 (Values in Cr)
Revenue 193.35
Operating Expense 190.04
Net Profit 2.67
Net Profit Margin (%) 1.38
Earnings Per Share (EPS) 2.80
EBITDA 7.45
Effective Tax Rate (%) 25.13
Particulars MAR 2020 (Values in Cr)
Revenue 147.98
Operating Expense 146.28
Net Profit 1.28
Net Profit Margin (%) 0.86
Earnings Per Share (EPS) 1.34
EBITDA 4.79
Effective Tax Rate (%) 25.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.96
ROE % 10.77
ROCE % 15.24
Total Debt to Total Equity 0.49
EBITDA Margin 3.42
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.54
ROE % 20.08
ROCE % 18.67
Total Debt to Total Equity 1.15
EBITDA Margin 3.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 23.58
ROE % 12.61
ROCE % 14.63
Total Debt to Total Equity 1.19
EBITDA Margin 3.90
Particulars MAR 2020 (Values in Cr)
Book Value / Share 20.78
ROE % 6.45
ROCE % 10.92
Total Debt to Total Equity 1.05
EBITDA Margin 3.23
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.96
ROE % 10.77
ROCE % 15.24
Total Debt to Total Equity 0.49
EBITDA Margin 3.43
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.55
ROE % 20.08
ROCE % 18.67
Total Debt to Total Equity 1.15
EBITDA Margin 3.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 23.58
ROE % 12.61
ROCE % 14.63
Total Debt to Total Equity 1.19
EBITDA Margin 3.90
Particulars MAR 2020 (Values in Cr)
Book Value / Share 20.78
ROE % 6.63
ROCE % 12.01
Total Debt to Total Equity 0.91
EBITDA Margin 3.23
Particulars MAR 2019 (Values in Cr)
Book Value / Share 19.63
ROE % 17.22
ROCE % 19.51
Total Debt to Total Equity 0.91
EBITDA Margin 3.76
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.71
Total Assets 232.47
Total Liabilities 232.47
Total Equity 100.97
Share Outstanding 24065887
Price to Book Ratio 1.33
Return on Assets (%) 3.02
Return on Capital (%) 5.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.23
Total Assets 137.52
Total Liabilities 137.52
Total Equity 29.77
Share Outstanding 9748998
Price to Book Ratio 0.00
Return on Assets (%) 3.81
Return on Capital (%) 8.69
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.25
Total Assets 99.26
Total Liabilities 99.26
Total Equity 22.55
Share Outstanding 9748998
Price to Book Ratio 0.00
Return on Assets (%) 2.69
Return on Capital (%) 5.42
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.71
Total Assets 232.46
Total Liabilities 232.46
Total Equity 100.98
Share Outstanding 24065887
Price to Book Ratio 1.33
Return on Assets (%) 3.02
Return on Capital (%) 5.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 137.51
Total Liabilities 137.51
Total Equity 29.78
Share Outstanding 9748998
Price to Book Ratio 0.00
Return on Assets (%) 3.81
Return on Capital (%) 8.7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.15
Total Assets 99.21
Total Liabilities 99.21
Total Equity 22.50
Share Outstanding 9546998
Price to Book Ratio 0.00
Return on Assets (%) 2.69
Return on Capital (%) 5.11
Particulars MAR 2023 (Values in Cr)
Net Income 9.49
Cash from Operations -26.68
Cash from Investing -25.65
Cash from Financing 65.92
Net change in Cash 11.48
Free Cash Flow -12.36
Particulars MAR 2022 (Values in Cr)
Net Income 7.13
Cash from Operations -2.05
Cash from Investing -1.45
Cash from Financing 4.26
Net change in Cash -1.01
Free Cash Flow -0.93
Particulars MAR 2021 (Values in Cr)
Net Income 3.57
Cash from Operations 3.60
Cash from Investing -1.29
Cash from Financing -1.48
Net change in Cash -0.01
Free Cash Flow 4.92
Particulars MAR 2020 (Values in Cr)
Net Income 1.71
Cash from Operations 0.97
Cash from Investing -2.38
Cash from Financing -0.27
Net change in Cash -2.14
Free Cash Flow 5.01
Particulars MAR 2023 (Values in Cr)
Net Income 9.49
Cash from Operations -26.68
Cash from Investing -25.65
Cash from Financing 65.92
Net change in Cash 11.48
Free Cash Flow -12.35
Particulars MAR 2022 (Values in Cr)
Net Income 7.13
Cash from Operations -1.93
Cash from Investing -1.53
Cash from Financing 4.30
Net change in Cash -0.92
Free Cash Flow -0.81
Particulars MAR 2021 (Values in Cr)
Net Income 3.57
Cash from Operations 3.71
Cash from Investing -1.34
Cash from Financing -1.63
Net change in Cash -0.11
Free Cash Flow 5.03
Particulars MAR 2020 (Values in Cr)
Net Income 1.71
Cash from Operations 0.97
Cash from Investing -2.52
Cash from Financing -0.27
Net change in Cash -2.29
Free Cash Flow 5.01
Particulars MAR 2019 (Values in Cr)
Net Income 3.26
Cash from Operations -0.09
Cash from Investing -3.49
Cash from Financing 7.95
Net change in Cash 3.44
Free Cash Flow 3.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
SUDARSHAN PHARMA INDUSTRIES LI 94.85 19.93 2.04 228.26 58.20 / 95.69
AEGIS LOGISTICS LIMITED 868.00 54.35 7.82 30466.80 280.00 / 969.95
AMBALAL SARABHAI ENTERPRISES L 71.24 96.27 3.98 545.94 26.05 / 77.70
KOTHARI INDUSTRIAL CORPORATION 10.02 0.60 -1.81 19.15 1.80 / 10.02
MYSORE PETRO CHEMICALS LTD. 172.40 15.19 0.51 113.50 121.10 / 235.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
SUDARSHAN PHARMA INDUSTRIES LI 94.85 20.10 2.04 228.26 58.20 / 95.69
AEGIS LOGISTICS LIMITED 868.00 75.09 12.78 30466.80 280.00 / 969.95
AMBALAL SARABHAI ENTERPRISES L 71.24 209.53 13.54 545.94 26.05 / 77.70
COMPUTER POINT LTD. 10.54 0.00 0.94 31.62 2.26 / 11.63
NOVARTIS INDIA LTD. 1168.85 34.68 3.87 2885.98 599.95 / 1224.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 90.00
  • 26 Days 81.10
  • 10 Days 87.30
  • 50 Days 77.90
  • 12 Days 86.80
  • 100 Days 75.00
  • 20 Days 83.90
  • 200 Days 81.90
93.15
PIVOT
First Resistance 97.39
Second Resistance 99.94
Third Resistance 104.18
First Support 90.60
Second Support 86.36
Third Support 83.81
RSI 78.09
MACD 5.73
Commodity Channel Index (CCI) 213.22
ADX 68.69
Williams % R -5.35

Over 1 Month

down

18.77

Over 3 Months

down

21.60

Over 6 Months

down

20.42

Over 1 Year

down

50.55

Over 3 Years

down

0.00

Over 5 Years

down

0.00

SUDARSHAN PHARMA INDUSTRIES LI Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SUDARSHAN PHARMA INDUSTRIES LI Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
41.2
Promoter Holdings
57.38
FII
1.4
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sachin Vasantrai Mehta Shareholding of Promoter and Promoter Group 6620547.0 27.51
Hemal Vasantrai Mehta Shareholding of Promoter and Promoter Group 6402102.0 26.6
Gretex Share Broking Limited Public Shareholding 969600.0 4.03
Harish Kumar Rijhwani Public Shareholding 649600.0 2.7
Vishwamani Tiwari Huf Public Shareholding 540000.0 2.24
Magicremedi Private Limited Public Shareholding 525000.0 2.18
Indian Infotech And Software Limited Public Shareholding 368000.0 1.53
Prashant Narinderlal Chadha Public Shareholding 312000.0 1.3
Neelam Sethia Public Shareholding 272000.0 1.13
Devangi Hemal Mehta Shareholding of Promoter and Promoter Group 229407.0 0.95
Namrata Sachin Mehta Shareholding of Promoter and Promoter Group 164512.0 0.68
Sachin V Mehta Huf Shareholding of Promoter and Promoter Group 164512.0 0.68
Hemal V Mehta Huf Shareholding of Promoter and Promoter Group 164512.0 0.68
Vasantray Ratilal Mehta Shareholding of Promoter and Promoter Group 49319.0 0.2
Jatin Vasantrai Mehta Shareholding of Promoter and Promoter Group 16447.0 0.07

SUDARSHAN PHARMA INDUSTRIES LI

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-08-25 0.3 Final 2023-08-26 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SUDARSHAN PHARMA INDUSTRIES LI

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SUDARSHAN PHARMA INDUSTRIES LI

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sudarshan Pharma Industries Ltd?

Answer Field

The share price of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.00 and for BSE is ₹ 100.00.

What is the Market Cap of Sudarshan Pharma Industries Ltd?

Answer Field

The market cap of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 240.70 Cr. as of now.

What is the 52 Week High and Low of Sudarshan Pharma Industries Ltd?

Answer Field

The 52 Week High and Low of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 100.00 and ₹ 58.20.

How to Buy Sudarshan Pharma Industries Ltd share?

Answer Field

You can trade in Sudarshan Pharma Industries Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sudarshan Pharma Industries Ltd?

Answer Field

The 1 year returns on the stock has been 50.55%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader